Kilitch Drugs (India) バランスシートの健全性
財務の健全性 基準チェック /56
Kilitch Drugs (India)の総株主資本は₹1.9B 、総負債は₹324.1Mで、負債比率は17.2%となります。総資産と総負債はそれぞれ₹2.6Bと₹709.5Mです。 Kilitch Drugs (India)の EBIT は₹154.0Mで、利息カバレッジ比率3.4です。現金および短期投資は₹588.5Mです。
主要情報
17.2%
負債資本比率
₹324.12m
負債
| インタレスト・カバレッジ・レシオ | 3.4x |
| 現金 | ₹588.52m |
| エクイティ | ₹1.88b |
| 負債合計 | ₹709.50m |
| 総資産 | ₹2.59b |
財務の健全性に関する最新情報
Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05
These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03
Recent updates
Kilitch Drugs (India) Limited (NSE:KILITCH) Not Flying Under The Radar
Jul 23Here's Why Kilitch Drugs (India) (NSE:KILITCH) Can Manage Its Debt Responsibly
Mar 05Kilitch Drugs (India) Limited (NSE:KILITCH) Looks Just Right With A 26% Price Jump
Feb 02We Ran A Stock Scan For Earnings Growth And Kilitch Drugs (India) (NSE:KILITCH) Passed With Ease
Jan 30Investors Shouldn't Be Too Comfortable With Kilitch Drugs (India)'s (NSE:KILITCH) Earnings
Nov 17Shareholders Would Not Be Objecting To Kilitch Drugs (India) Limited's (NSE:KILITCH) CEO Compensation And Here's Why
Sep 23These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Sep 08Here's Why Kilitch Drugs (India) (NSE:KILITCH) Has Caught The Eye Of Investors
May 05Kilitch Drugs (India) (NSE:KILITCH) Could Easily Take On More Debt
Jul 06Here's Why I Think Kilitch Drugs (India) (NSE:KILITCH) Might Deserve Your Attention Today
Apr 08These 4 Measures Indicate That Kilitch Drugs (India) (NSE:KILITCH) Is Using Debt Reasonably Well
Dec 17Is Kilitch Drugs (India) (NSE:KILITCH) Using Too Much Debt?
Mar 21Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Feb 13Is Kilitch Drugs (India) (NSE:KILITCH) Weighed On By Its Debt Load?
Dec 03Does Kilitch Drugs (India) Limited (NSE:KILITCH) Have A Place In Your Dividend Stock Portfolio?
Aug 20Should Weakness in Kilitch Drugs (India) Limited's (NSE:KILITCH) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jul 16財務状況分析
短期負債: KILITCHの 短期資産 ( ₹1.5B ) が 短期負債 ( ₹707.8M ) を超えています。
長期負債: KILITCHの短期資産 ( ₹1.5B ) が 長期負債 ( ₹1.7M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: KILITCH総負債よりも多くの現金を保有しています。
負債の削減: KILITCHの負債対資本比率は、過去 5 年間で10.9%から17.2%に増加しました。
債務返済能力: KILITCHの負債は 営業キャッシュフロー によって 十分にカバー されています ( 64.9% )。
インタレストカバレッジ: KILITCHの負債に対する 利息支払い は EBIT ( 3.4 x coverage) によって 十分にカバーされています。